Table of Contents

1. Introduction
 1.1 Market Definition & Scope
 1.2 Research Assumptions & Abbreviations
 1.3 Research Methodology

2. Executive Summary
 2.1 Market Snapshot
 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022 – 2033
 2.3 Market Size & Forecast, By Segmentation, 2022 – 2033
  2.3.1 Market Size By Product
  2.3.2 Market Size By Application
  2.3.3 Market Size By End-Users
 2.4 Market Share & Bps Analysis By Region, 2024
 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
 2.6 Industry CxO’s Perspective

3. Market Overview
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Key Market Trends
 3.2 Industry PESTLE Analysis
 3.3 Key Industry Forces (Porter’s) Impacting Market Growth
 3.4 Industry Supply Chain Analysis
  3.4.1 Raw Material Suppliers
  3.4.2 Manufacturers
  3.4.3 Distributors/Suppliers
  3.4.4 Customers/End-Users
 3.5 Industry Life Cycle Assessment
 3.6 Parent Market Overview
 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting
 4.1 Procedure Volume & Utilization Analysis
  4.1.1 Overview
  4.1.2 Annual Angioplasty Procedures (Coronary vs. Peripheral)
  4.1.3 Average Number of Balloons Used per Procedure
  4.1.4 Utilization Rate by Balloon Type (Normal vs. Specialty)
  4.1.5 Forecasted Procedure Growth in Emerging Economies
 4.2 Regulatory & Reimbursement Landscape
  4.2.1 Overview
  4.2.2 FDA PMA & 510(k) Approvals for Novel Balloon Technologies
  4.2.3 Reimbursement Code Analysis (CPT/HCPCS) and Payer Policies
  4.2.4 Impact of CMS Bundled Payment Initiatives on Product Adoption
  4.2.5 Regional Approval Pathways: CE Mark, NMPA, PMDA
 4.3 Pipeline & Innovation Metrics
  4.3.1 Overview
  4.3.2 Number of Next-Gen Balloons in Clinical Trials (e.g., Sirolimus-Eluting, Lithotripsy)
  4.3.3 Average R&D Investment as % of Revenue by Key Players
  4.3.4 Patent Analysis: Key Areas of Innovation (Coating Technology, Bioresorbable Polymers)
  4.3.5 Time-to-Market for New Balloon Platforms
 4.4 Pricing & Cost-Benefit Analysis
  4.4.1 Overview
  4.4.2 Average Selling Price (ASP) Trend Analysis by Product Type
  4.4.3 Cost-Benefit Assessment: Drug-Eluting vs. Conventional Balloons
  4.4.4 Price Benchmarking Across Key Geographies (US, EU, APAC)
  4.4.5 Impact of Generic/Bio-similar Balloons on Market Pricing

5. Angioplasty Balloon Market Segmental Analysis & Forecast, By Product, 2022 – 2033, Value (USD Million)
 5.1 Introduction
 5.2 Normal Balloons
  5.2.1 Key Trends
  5.2.2 Market Size & Forecast, 2022 – 2033
 5.3 Cutting/Scoring Balloons
 5.4 Drug-Eluting Balloons

6. Angioplasty Balloon Market Segmental Analysis & Forecast, By Application, 2022 – 2033, Value (USD Million)
 6.1 Introduction
 6.2 Coronary Angioplasty
  6.2.1 Key Trends
  6.2.2 Market Size & Forecast, 2022 – 2033
 6.3 Peripheral Angioplasty

7. Angioplasty Balloon Market Segmental Analysis & Forecast, By End-Users, 2022 – 2033, Value (USD Million)
 7.1 Introduction
 7.2 Hospitals
  7.2.1 Key Trends
  7.2.2 Market Size & Forecast, 2022 – 2033
 7.3 Ambulatory Surgical Centers (ASCs)
 7.4 Others

8. Angioplasty Balloon Market Segmental Analysis & Forecast By Region, 2022 – 2033, Value (USD Million)
 8.1 Introduction
 8.2 North America
  8.2.1 Key Trends
  8.2.2 Market Size & Forecast, By Product, 2022 – 2033
  8.2.3 Market Size & Forecast, By Application, 2022 – 2033
  8.2.4 Market Size & Forecast, By End-Users, 2022 – 2033
  8.2.5 Market Size & Forecast, By Country, 2022 – 2033
   8.2.5.1 USA
   8.2.5.2 Canada
 8.3 Europe
  8.3.1 Key Trends
  8.3.2 Market Size & Forecast, By Product, 2022 – 2033
  8.3.3 Market Size & Forecast, By Application, 2022 – 2033
  8.3.4 Market Size & Forecast, By End-Users, 2022 – 2033
  8.3.5 Market Size & Forecast, By Country, 2022 – 2033
   8.3.5.1 Germany
   8.3.5.2 UK
   8.3.5.3 France
   8.3.5.4 Italy
   8.3.5.5 Spain
   8.3.5.6 Russia
   8.3.5.7 Poland
   8.3.5.8 Rest of Europe
 8.4 Asia-Pacific
  8.4.1 Key Trends
  8.4.2 Market Size & Forecast, By Product, 2022 – 2033
  8.4.3 Market Size & Forecast, By Application, 2022 – 2033
  8.4.4 Market Size & Forecast, By End-Users, 2022 – 2033
  8.4.5 Market Size & Forecast, By Country, 2022 – 2033
   8.4.5.1 China
   8.4.5.2 India
   8.4.5.3 Japan
   8.4.5.4 South Korea
   8.4.5.5 Australia
   8.4.5.6 ASEAN Countries
   8.4.5.7 Rest of Asia-Pacific
 8.5 Latin America
  8.5.1 Key Trends
  8.5.2 Market Size & Forecast, By Product, 2022 – 2033
  8.5.3 Market Size & Forecast, By Application, 2022 – 2033
  8.5.4 Market Size & Forecast, By End-Users, 2022 – 2033
  8.5.5 Market Size & Forecast, By Country, 2022 – 2033
   8.5.5.1 Brazil
   8.5.5.2 Argentina
   8.5.5.3 Mexico
   8.5.5.4 Colombia
   8.5.5.5 Rest of Latin America
 8.6 Middle East & Africa
  8.6.1 Key Trends
  8.6.2 Market Size & Forecast, By Product, 2022 – 2033
  8.6.3 Market Size & Forecast, By Application, 2022 – 2033
  8.6.4 Market Size & Forecast, By End-Users, 2022 – 2033
  8.6.5 Market Size & Forecast, By Country, 2022 – 2033
   8.6.5.1 UAE
   8.6.5.2 Saudi Arabia
   8.6.5.3 Qatar
   8.6.5.4 Egypt
   8.6.5.5 South Africa
   8.6.5.6 Rest of Middle East & Africa

9. Competitive Landscape
 9.1 Key Players' Positioning
 9.2 Competitive Developments
  9.2.1 Key Strategies Adopted (%), By Key Players, 2024
  9.2.2 Year-Wise Strategies & Development, 2021 – 2025
  9.2.3 Number Of Strategies Adopted By Key Players, 2024
 9.3 Market Share Analysis, 2024
 9.4 Product/Service & Application Benchmarking
  9.4.1 Product/Service Specifications & Features By Key Players
  9.4.2 Product/Service Heatmap By Key Players
  9.4.3 Application Heatmap By Key Players
 9.5 Industry Start-Up & Innovation Landscape
 9.6 Key Company Profiles
  9.6.1 Boston Scientific Corporation
   9.6.1.1 Company Overview & Snapshot
   9.6.1.2 Product/Service Portfolio
   9.6.1.3 Key Company Financials
   9.6.1.4 SWOT Analysis
  9.6.2 Medtronic plc
  9.6.3 Abbott Laboratories
  9.6.4 Becton, Dickinson and Company (BD)
  9.6.5 Terumo Corporation
  9.6.6 B. Braun Melsungen AG
  9.6.7 Cook Medical
  9.6.8 Cardinal Health (Cordis)
  9.6.9 BIOTRONIK SE & Co. KG
  9.6.10 Teleflex Incorporated
  9.6.11 AngioDynamics
  9.6.12 Koninklijke Philips N.V.
  9.6.13 MicroPort Scientific Corporation
  9.6.14 Nipro Medical Corporation
  9.6.15 Shockwave Medical Inc.
  9.6.16 Concept Medical Inc.
  9.6.17 Spectranetics Corporation
  9.6.18 Biomerics
  9.6.19 Hexacath
  9.6.20 Elixir Medical Corporation

10. Analyst Recommendations
 10.1 SNS Insider Opportunity Map
 10.2 Industry Low-Hanging Fruit Assessment
 10.3 Market Entry & Growth Strategy
 10.4 Analyst Viewpoint & Suggestions on Market Growth

11. Assumptions

12. Disclaimer

13. Appendix
 13.1 List Of Tables
 13.2 List Of Figure